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Fig.　1a　Histopathological effect of OLP on the skin lesions 
of DS-Nh mice. The total histology score is shown. Each 
point represents the mean value ± standard error of the mean 
(SEM) of 5 mice. **P < 0.01, and ***P < 0.001: signifi cantly 
different from the control group (Mann-Whitney two-sided U 
test).
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Dear Editor
Histamine H1-Receptor Antagonistic
Drug Olopatadine Suppresses TSLP
in Atopic Dermatitis Model Mice
Olopatadine hydrochloride ( OLP ) is as second-
generation, anti-histamines, H1-receptor antagonistic
drug that is used for treating allergic rhinititis, urti-
caria, and various eczemas. Some studies reported
that OLP suppressed the productions by epithelial
cells and mast cells of several chemical mediators
and Th2 cytokineschemokaines in vivo and vitro.1,2
In this study, to evaluate the expression levels of an-
other factors, we examined whether OLP suppressed
thymic stromal lymphopoietin (TSLP), and evaluated
the levels of Th2 cytokines in lesional skin of atopic
dermatitis model mice with quantitative real-time RT-
PCR. The DS non-hair (DS-Nh) mice are a model of
human atopic dermatitis (AD), that spontaneously de-
velops dermatitis under conventional conditions as
described previously.3-6
Male Ds-Nhmice were obtained as F1 (Nh+) from
male Ds-Nh (NhNh) × female DS (++) mice housed
under specific pathogen-free (SPF) conditions for 5
weeks. The animals were then moved to conventional
conditions. Subsequently, we subcutaneously in-
jected saline into the abdominal region of mice and
administered OLP (10 mgkgday) 5 days a week for
a total of 11 weeks. The control mice were adminis-
tered saline through the esophagus during the same
period. First, tissues were obtained via biopsy from
facial lesional skin at 10-16 weeks of age. Samples
were then fixed in 10% formalin and prepared for he-
matoxylin and eosin (HE) staining. Clinically, erythe-
mas, edema, and slight erosions were observed on
the faces of control Ds-Nh mice. Histopathologically,
hyperkeratosis, acanthosis, and infiltration of lympho-
cytes were apparent in skin lesions of control Ds-Nh
mice, and these changes were prominently attenu-
ated by treatment with oral OLP. In this study, the
histological findings were evaluated as reported pre-
viously.6 In brief, samples were scored for the sever-
ity and character of the inflammatory response using
a subjective grading scale. Responses were graded as
follows: 0, no response; 1, minimal response; 2, mild
response; 3, moderate response; and 4, marked re-
sponse. The slides were blinded, randomized, and re-
read to determine the histology score. All of the
slides were evaluated by the same deramtopatholo-
gist using the same subjective grading scale. The to-
tal histology score was calculated, where this in-
cluded inflammation, neutrophils, mononuclear cells,
edema, epithelial hyperplasia, and mast cells.
The tissues obtained by biopsies of half of the facial
lesions of Ds-Nh mice were frozen and stored at
-80℃. Total RNA was extracted using RNeasy Mini
Kits according to the manufacturer’s instructions
(Qiagen, Valencia, CA, USA). Quantitative real-time
RT-PCR was performed as described previously.6 Oli-
gonucleotide primers and probes specific for IL-4,
CCL24, and TSLP were used in this study. For each
sample, triplicate test reactions and a control reaction
lacking reverse transcriptase were analyzed for gene
expression and the results were normalized to those
of the ‘ housekeeping’ glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) mRNA.
Histamine is a biogenic amine and an important
mediator in various allergic and inflammatory condi-
tions. It exerts the effects through the activation of
four distinct histamine receptors that belong to the G-
protein-coupled-receptor superfamily. 7 OLP has an
antagonisitic action against histamine H1 receptor
and inhibits the release of various chemical media-
tors and Th2 cytokineschemokaines.2
In this study, the total histologic score of the con-
trol Ds-Nhmice groups showed more severe dermati-
tis compared with the OLP groups (Fig. 1a). In con-
trast previous report indicated that OLP suppressed
IL-4 expressions in NCNga mice.2 However, in our
experiments, the IL-4 expressions did not have a dif-
ference between control and OLP groups at only 10-
12 weeks. This result suggested that the difference of
IL-4 expressions seemed to be due to murine or envi-
ronmental difference. The expression of TSLP mRNA
in Ds-Nh mice that received OLP was lower than the
levels in control Ds-Nh mice (Fig. 1b). Similarly, the
expression of IL-4, CCL 24 and TSLP mRNA
increased at 10-16 weeks in control Ds-Nh mice (Fig.
1b). Recent studies have revealed that TSLP is not
only expressed by epithelial cells and keratinocytes
but also by mast cells, fibroblasts, dendritic cells, and
various other cells. In contrast TSLP expression in
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Fig.　1b　OLP inhibits cytokine expressions in skin lesions 
of DS-Nh mice. Quantitative real-time PCR was performed to 
evaluate the expression levels of IL-4, CCL24, and thymic 
stromal lymphopoietin (TSLP) in the skin lesions of Ds-Nh 
mice with or without olopatadine treatment at ages 10-16 
weeks. Glyceraldehyde-3-phosphate-dehydrogenase (GAP
DH) was used as a control to normalize for differences in 
each sample. Data are shown as the mean ± SEM, *P < 
0.05, **P < 0.01, and ***P < 0.001 (Mann-Whitney two-sided 
U test).
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the lesional skin is significantly elevated especially in
the epidermis with acute and chronic AD, but not in
uninvolved skin of the patients.8 Our data indicated
that TSLP expressions were significantly suppressed
as well as IL-4 and CCL24 expression by OLP. How-
ever, the target cells of OLP are unknown, and future
studies in AD model mice are needed.
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